Doxylamine Pills: Usage Guidelines and Side Effects
Primary Indication and Dosing
Doxylamine is an over-the-counter antihistamine approved for short-term treatment of occasional insomnia in adults, dosed at 25 mg taken 30 minutes before bedtime. 1
Approved Dosing
- Adults and children ≥12 years: One 25 mg tablet taken 30 minutes before bedtime, once daily 1
- Children <12 years: Contraindicated—do not use 1
- Available in 12.5 mg and 25 mg strengths with dose-proportional pharmacokinetics 2
Clinical Context and Guideline Position
Current clinical practice guidelines do not recommend doxylamine or other antihistamines as preferred treatment for chronic insomnia. The American Academy of Sleep Medicine states antihistamines have "very limited" evidence for efficacy and safety, with "potential for serious side effects arising from their concurrent anticholinergic properties." 3 Long-term use of over-the-counter antihistamine treatments is not recommended due to limited safety and efficacy data. 3
Guideline-Recommended Alternatives
- First-line: Cognitive Behavioral Therapy for Insomnia (CBT-I) 3, 4
- First-line pharmacotherapy: Zolpidem 5 mg, ramelteon 8 mg, or other benzodiazepine receptor agonists 3, 4
- Second-line: Low-dose doxepin 3-6 mg (different from doxylamine) 3, 4
- Third-line: Sedating antidepressants for comorbid depression/anxiety 3, 4
- Last resort only: Antihistamines like doxylamine after other options have failed 3
Contraindications and Precautions
Absolute Contraindications
- Children under 12 years of age 1
- Pregnancy and breastfeeding: Consult healthcare professional before use 1
Relative Contraindications—Consult Physician Before Use
- Respiratory conditions: Asthma, emphysema, or chronic bronchitis 1
- Glaucoma 1
- Urinary retention: Enlarged prostate gland 1
- Renal impairment: May require dose adjustment 3
Common Side Effects
Expected Anticholinergic Effects
- Somnolence (most common adverse event) 2
- Dry mouth 1
- Urinary retention (particularly in elderly males with prostatic hypertrophy) 1
- Blurred vision (anticholinergic effect) 1
Important Safety Warnings
- Avoid alcohol: Concurrent use increases sedation risk 1
- Take only at bedtime: Due to prolonged sedative effects 1
- Next-day impairment: Residual drowsiness may affect driving and activities requiring alertness 1
Serious Adverse Effects and Toxicity
Overdose Manifestations
- Seizures (anticholinergic toxicity) 5
- Rhabdomyolysis (potentially delayed presentation) 5
- Anticholinergic syndrome: Confusion, agitation, hyperthermia 5
- Death in severe overdose cases 6, 5
Overdose Management
- Immediate action: Contact Poison Control Center (1-800-222-1222) or seek emergency medical care 1
- Supportive care: Symptomatic management, monitor for delayed rhabdomyolysis 5
- False positive drug screens: Doxylamine toxicity can cause false positive urine immunoassay results for methadone and phencyclidine 5
Abuse Potential and Dependence
Doxylamine has documented abuse and addiction potential despite over-the-counter availability. Case reports describe patients escalating from therapeutic doses (25 mg/day) to 125 mg/day over years of continuous use. 7 This underscores the importance of limiting duration of use.
Duration of Use Recommendations
Discontinue and consult a physician if sleeplessness persists continuously for more than 2 weeks, as insomnia may indicate serious underlying medical illness. 1 Ideally, use should be limited to 2-4 weeks maximum. 3
Drug Interactions
- Avoid concurrent use with other sedating medications 1
- Alcohol potentiates sedative effects 1
- Other anticholinergic drugs: Additive anticholinergic burden 1
Special Considerations for Pregnancy
The European Association for the Study of the Liver recommends doxylamine and pyridoxine as first-line pharmacologic treatment for hyperemesis gravidarum, indicating some safety data exists for pregnancy use in this specific context. 8 However, the FDA drug label still recommends consulting a healthcare professional before use if pregnant or breastfeeding. 1
Clinical Bottom Line
For occasional insomnia in healthy adults without contraindications, doxylamine 25 mg at bedtime may provide short-term relief, but should not be used for more than 2 weeks without physician consultation. 1 Patients with chronic insomnia should be directed toward evidence-based treatments including CBT-I or guideline-recommended pharmacotherapy rather than continued antihistamine use. 3, 4